NO995455D0 - 4-Fenylpiperidinforbindelser - Google Patents

4-Fenylpiperidinforbindelser

Info

Publication number: NO995455D0
Authority: NO; Norway
Prior art keywords: alkyl; phenyl; halo; alkoxy; trifluoroalkyl
Prior art date: 1997-06-10

Application number

NO995455A

Other languages

English (en)

Other versions

NO995455L (no

NO317371B1 (no

Inventor

Franciscus Bernardus Benneker

Frans Van Dalen

Jacobus Maria Lemmens

Theodorus Hendricus Ant Peters

Frantisek Pycha

Original Assignee

Synthon Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-10

Filing date

1999-11-08

Publication date

1999-11-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26647319&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995455(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-11-08 Application filed by Synthon Bv filed Critical Synthon Bv

1999-11-08 Publication of NO995455D0 publication Critical patent/NO995455D0/no

2000-02-09 Publication of NO995455L publication Critical patent/NO995455L/no

2004-10-18 Publication of NO317371B1 publication Critical patent/NO317371B1/no

Links

125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title abstract 3
125000000217 alkyl group Chemical group 0.000 abstract 6
125000003545 alkoxy group Chemical group 0.000 abstract 3
125000001475 halogen functional group Chemical group 0.000 abstract 3
-1 methylsulphonyl Chemical group 0.000 abstract 3
125000000304 alkynyl group Chemical group 0.000 abstract 2
125000004950 trifluoroalkyl group Chemical group 0.000 abstract 2
UTBULQCHEUWJNV-UHFFFAOYSA-N 4-phenylpiperidine Chemical class C1CNCCC1C1=CC=CC=C1 UTBULQCHEUWJNV-UHFFFAOYSA-N 0.000 abstract 1
125000004442 acylamino group Chemical group 0.000 abstract 1
125000004414 alkyl thio group Chemical group 0.000 abstract 1
125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO19995455A 1997-06-10 1999-11-08 4-Fenylpiperidinforbindelser NO317371B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/872,023 US5874447A (en)	1997-06-10	1997-06-10	4-Phenylpiperidine compounds for treating depression
PCT/NL1997/000328 WO1998056787A1 (en)	1997-06-10	1997-06-10	4-Phenylpiperidine compounds

Publications (3)

Publication Number	Publication Date
NO995455D0 true NO995455D0 (no)	1999-11-08
NO995455L NO995455L (no)	2000-02-09
NO317371B1 NO317371B1 (no)	2004-10-18

Family

ID=26647319

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO19995455A NO317371B1 (no)	1997-06-10	1999-11-08	4-Fenylpiperidinforbindelser
NO20033766A NO20033766D0 (no)	1997-06-10	2003-08-25	4-Fenylpiperidinforbindelser
NO20033765A NO20033765D0 (no)	1997-06-10	2003-08-25	4-Fenylpiperidinforbindelser

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
NO20033766A NO20033766D0 (no)	1997-06-10	2003-08-25	4-Fenylpiperidinforbindelser
NO20033765A NO20033765D0 (no)	1997-06-10	2003-08-25	4-Fenylpiperidinforbindelser

Country Status (25)

Country	Link
US (4)	US5874447A (no)
EP (2)	EP0994872B9 (no)
JP (1)	JP2002503248A (no)
KR (1)	KR100543614B1 (no)
AT (1)	ATE200781T1 (no)
AU (1)	AU3108097A (no)
BG (1)	BG64315B1 (no)
BR (1)	BR9714787A (no)
CA (1)	CA2293247C (no)
CZ (1)	CZ295301B6 (no)
DE (2)	DE69704679T2 (no)
DK (1)	DK0994872T3 (no)
EE (2)	EE03970B1 (no)
ES (1)	ES2155995T3 (no)
GR (1)	GR3035784T3 (no)
HU (1)	HUP0003141A3 (no)
IL (1)	IL133366A (no)
IS (2)	IS1927B (no)
NO (3)	NO317371B1 (no)
PL (1)	PL188450B1 (no)
PT (1)	PT994872E (no)
SI (1)	SI0994872T1 (no)
SK (1)	SK283394B6 (no)
TR (2)	TR199903025T2 (no)
WO (1)	WO1998056787A1 (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU221921B1 (hu) *	1996-07-08	2003-02-28	Richter Gedeon Vegyészeti Gyár Rt.	N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
EA200001050A1 (ru) *	1998-04-09	2001-04-23	Смитклайн Бичам Плс	Малеат пароксетина
AU724845B3 (en) *	1998-07-02	2000-09-28	Smithkline Beecham Plc	Novel compound
US20010023252A1 (en) *	1998-07-02	2001-09-20	Smithkline Beecham Plc	Novel compound
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB9814316D0 (en) *	1998-07-02	1998-09-02	Smithkline Beecham Plc	Novel compounds
EP1102764A1 (en) *	1998-08-08	2001-05-30	Smithkline Beecham Plc	Paroxetine salts
GB9827431D0 (en) *	1998-12-11	1999-02-03	Smithkline Beecham Plc	Novel compound
GB9828779D0 (en) *	1998-12-29	1999-02-17	Smithkline Beecham Plc	Novel process
GB9828780D0 (en) *	1998-12-29	1999-02-17	Smithkline Beecham Plc	Novel process
GB9828781D0 (en) *	1998-12-29	1999-02-17	Smithkline Beecham Plc	Novel process
GB9914585D0 (en) *	1999-06-22	1999-08-25	Smithkline Beecham Plc	Novel process
ES2159260B1 (es) *	1999-06-22	2002-05-01	Smithkline Beechan Plc	Nueva composicion de metanosulfonato de paroxetina
AU5078700A (en) *	1999-06-22	2001-01-09	Smithkline Beecham Plc	Novel composition
KR100759159B1 (ko) *	1999-07-01	2007-09-14	이탈파마코 에스.피.에이.	파록세틴과 사이클로덱스트린 또는 사이클로덱스트린유도체의 컴플렉스
GB9919052D0 (en) *	1999-08-12	1999-10-13	Smithkline Beecham Plc	Novel compound composition and process
US6503927B1 (en) *	1999-10-28	2003-01-07	Pentech Pharmaceuticals, Inc.	Amorphous paroxetine composition
USRE46117E1 (en)	1999-12-22	2016-08-23	Teva Pharmaceuticals International Gmbh	Modulators of dopamine neurotransmission
DK1286965T3 (da) *	2000-05-12	2004-05-03	Synthon Bv	Piperidin-forbindelser og fremgangsmåder til fremstilling af sådanne
CZ20023694A3 (cs) *	2000-05-12	2003-05-14	Synthon B. V.	Tosylátové soli 4-(p-fluorfenyl)-piperidin-3-methanolů
NZ523902A (en) *	2000-08-28	2004-05-28	Synthon Bv	Paroxetine compositions and processes for making the same
WO2002022609A1 (en) *	2000-09-14	2002-03-21	Asahi Glass Company, Limited	Process for producing paroxetine salt containing substantially no organic solvent
DE20100529U1 (de) *	2001-01-11	2001-05-10	Synthon Bv	Pharmazeutische Tablette umfassend Paroxetinmesylat
US6720003B2 (en) *	2001-02-16	2004-04-13	Andrx Corporation	Serotonin reuptake inhibitor formulations
NL1017421C2 (nl) *	2001-02-21	2002-01-15	Synthon Bv	Werkwijze voor het vervaardigen van paroxetine.
US20030032809A1 (en) *	2001-04-25	2003-02-13	Subhash P. Upadhyaya	Optimized procedures for the manufacture of paroxetine salts
AU2002318185A1 (en) *	2001-06-13	2002-12-23	Teva Pharmaceutical Industries Ltd.	Process for the preparation of paroxetine substantially free of alkoxy impurities
IL159280A0 (en) *	2001-06-14	2004-06-01	Teva Pharma	A process for preparing paroxetine hcl which limits formation of pink colored compounds
CA2456233A1 (en) *	2001-08-02	2003-03-13	Spurcourt Limited	Paroxetine isethionate salt, process of preparation and use in the treatment of depression
US20030181488A1 (en)	2002-03-07	2003-09-25	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
WO2003082804A1 (en) *	2002-03-28	2003-10-09	Synthon B.V.	Venlafaxine besylate
US20040220153A1 (en) *	2002-09-24	2004-11-04	Jost-Price Edward Roydon	Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US7202259B2 (en) *	2002-11-18	2007-04-10	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
PL1691811T3 (pl)	2003-12-11	2014-12-31	Sunovion Pharmaceuticals Inc	Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
WO2006018318A1 (en) *	2004-08-18	2006-02-23	Synthon B.V.	Liquid paroxetine compositions
WO2006023347A1 (en) *	2004-08-20	2006-03-02	Alpharma, Inc.	Paroxetine formulations
KR101380190B1 (ko) *	2005-07-29	2014-04-11	콘서트 파마슈티컬즈, 인크.	벤조 〔ｄ〕〔１,３〕―디옥솔 유도체
US20080033011A1 (en) *	2005-07-29	2008-02-07	Concert Pharmaceuticals Inc.	Novel benzo[d][1,3]-dioxol derivatives
US20070112031A1 (en) *	2005-11-14	2007-05-17	Gant Thomas G	Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
SE529246C2 (sv)	2005-10-13	2007-06-12	Neurosearch Sweden Ab	Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
US20080033050A1 (en)	2006-08-04	2008-02-07	Richards Patricia Allison Tewe	Method of treating thermoregulatory disfunction with paroxetine
MX2010002692A (es)	2007-09-13	2010-06-01	Concert Pharmaceuticals Inc	Sintesis de catecoles deuterados y derivados de benzo[d][1,3]dioxoles de los mismos.
US9138430B2 (en) *	2007-12-27	2015-09-22	Mylan Specialty L.P.	Formulation and method for the release of paroxetine in the large intestine
MY162940A (en)	2009-08-19	2017-07-31	Eisai R&D Man Co Ltd	Quinoline derivative-containing pharmaceutical composition
JP6038128B2 (ja)	2011-06-03	2016-12-07	エーザイ・アール・アンド・ディー・マネジメント株式会社	レンバチニブ化合物に対する甲状腺癌対象及び腎臓癌対象の反応性を予測及び評価するためのバイオマーカー
WO2013115163A1 (ja) *	2012-01-31	2013-08-08	エーザイ・アール・アンド・ディー・マネジメント株式会社	パロキセチン誘導体
AU2013243461A1 (en)	2012-04-04	2014-11-06	Teva Pharmaceuticals International Gmbh	Pharmaceutical compositions for combination therapy
PT3524595T (pt)	2014-08-28	2022-09-19	Eisai R&D Man Co Ltd	Derivado de quinolina altamente puro e método para produção do mesmo
LT3263106T (lt)	2015-02-25	2024-01-10	Eisai R&D Management Co., Ltd.	Chinolino darinių kartumo sumažinimo būdas
MX373231B (es)	2015-06-16	2020-05-08	Eisai R&D Man Co Ltd	Agente anticancerigeno.
US12220398B2 (en)	2015-08-20	2025-02-11	Eisai R&D Management Co., Ltd.	Tumor therapeutic agent
US12303505B2 (en)	2017-02-08	2025-05-20	Eisai R&D Management Co., Ltd.	Tumor-treating pharmaceutical composition
RU2019134940A (ru)	2017-05-16	2021-06-16	Эйсай Ар Энд Ди Менеджмент Ко., Лтд.	Лечение гепатоцеллюлярной карциномы

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT99678B (de) *	1921-09-21	1925-04-10	Hoechst Ag	Verfahren zur Darstellung arzneilich wirksamer Quecksilberverbindungen.
GB1422263A (en) *	1973-01-30	1976-01-21	Ferrosan As	4-phenyl-piperidine compounds
US4585777A (en) *	1984-02-07	1986-04-29	A/S Ferrosan	(-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT
GB8430581D0 (en) *	1984-12-04	1985-01-09	Ferrosan As	Treatment
EP0190496A3 (en) *	1984-12-13	1987-05-27	Beecham Group Plc	Piperidine derivatives having a gastro-intestinal activity
GB8520154D0 (en) *	1985-08-10	1985-09-18	Beecham Group Plc	Chemical process
EP0223334B1 (en) *	1985-08-10	1991-07-10	Beecham Group Plc	Process for the preparation of aryl-piperidine carbinols
EP0223403B1 (en) *	1985-10-25	1993-08-04	Beecham Group Plc	Piperidine derivative, its preparation, and its use as medicament
US5258388A (en) *	1986-03-17	1993-11-02	University Of Florida	Anticholinergic compounds, compositions and methods of treatment
IE66332B1 (en) *	1986-11-03	1995-12-27	Novo Nordisk As	Piperidine compounds and their preparation and use
GB8626936D0 (en) *	1986-11-11	1986-12-10	Ferrosan As	Treatment
GB8714707D0 (en) *	1987-06-23	1987-07-29	Beecham Group Plc	Chemical process
DK716088D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Reduktion af piperidin-dion-derivater samt intermediat
DK715988D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Etherifikation og dealkylering af piperidin-derivater samt intermediater
AU658155B2 (en)	1990-11-24	1995-04-06	Beecham Group Plc	Use of paroxetine for the treatment of senile dementia, or anorexia
GB9209687D0 (en) *	1992-05-06	1992-06-17	Smithkline Beecham Plc	Novel process
US5258517A (en) *	1992-08-06	1993-11-02	Sepracor, Inc.	Method of preparing optically pure precursors of paroxetine
JP2773587B2 (ja) *	1992-11-30	1998-07-09	東レ株式会社	Ｏ，ｏ´−ジアシル酒石酸無水物の製造法
US5276042A (en)	1993-04-16	1994-01-04	Crenshaw Roger T	Treatment of premature ejaculation
US5546683A (en) *	1993-09-29	1996-08-20	Clark; George J.	Bucket attachment device with remote controlled retractable pins
IT1274241B (it) *	1993-12-03	1997-07-15	Smithkline Beecham Farma	Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono
GB9325644D0 (en)	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation
US5668134A (en) *	1994-01-28	1997-09-16	G. D. Searle & Co.	Method for preventing or reducing photosensitivity and/or phototoxicity reactions to medications
GB9402029D0 (en) *	1994-02-03	1994-03-30	Smithkline Beecham Plc	Novel formulation
CA2143070C (en) *	1994-02-22	2001-12-18	Pankaj Modi	Oral controlled release liquid suspension pharmaceutical formulation
EP0714663A3 (en) *	1994-11-28	1997-01-15	Lilly Co Eli	Potentiation of drug responses by serotonin 1A receptor antagonists
JPH08220486A (ja) *	1994-12-14	1996-08-30	Kato Kogei:Kk	眼鏡フレーム
AR001982A1 (es) *	1995-02-06	1998-01-07	Smithkline Beecham Plc	Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
GB2297550B (en) *	1995-02-06	1997-04-09	Smithkline Beecham Plc	Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
US5856493A (en) *	1995-02-06	1999-01-05	Smithkline Beecham Corporation	Process for making novel form of paroxeting hydrochloride anhydrate
EP0818990A1 (en) *	1995-04-03	1998-01-21	Abbott Laboratories	Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
CN1068597C (zh) *	1995-05-17	2001-07-18	诺沃挪第克公司	制备4－芳基－哌啶衍生物的方法
JP2813768B2 (ja) *	1995-05-24	1998-10-22	農林水産省家畜衛生試験場長	口蹄疫診断用ペプチドおよび当該ペプチドを含有する口蹄疫診断用抗原
GB9514842D0 (en) *	1995-07-20	1995-09-20	Smithkline Beecham Plc	Novel formulation
AU701386B2 (en) *	1995-10-31	1999-01-28	Merck & Co., Inc.	Process for preparing substituted azetidinones
IT1276160B1 (it) *	1995-11-22	1997-10-27	Recordati Chem Pharm	Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
GB9526645D0 (en) *	1995-12-28	1996-02-28	Chiroscience Ltd	Stereoselective synthesis
ES2117557B1 (es) *	1996-02-29	1999-07-01	Ferrer Int	Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina.
JP3446468B2 (ja) *	1996-04-15	2003-09-16	旭硝子株式会社	ピペリジンカルビノール類の製造方法
CA2206592A1 (en) *	1996-05-30	1997-11-30	Shu-Zhong Wang	Method of producing amorphous paroxetine hydrochloride
JP3882224B2 (ja) *	1996-05-31	2007-02-14	旭硝子株式会社	パロキセチンの製造方法
EP1394160A1 (en) *	1996-06-13	2004-03-03	SUMIKA FINE CHEMICALS Co., Ltd.	Process for preparing crystalline paroxetin hydrochloride
HU221921B1 (hu) *	1996-07-08	2003-02-28	Richter Gedeon Vegyészeti Gyár Rt.	N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
US5672609A (en) *	1996-07-18	1997-09-30	Eli Lilly And Company	Pyridine compounds, intermediates compositions and methods of use
CA2187128A1 (en) *	1996-10-04	1997-06-26	K. S. Keshava Murthy	New and useful polymorph of anhydrous paroxetine hydrochloride
US5955475A (en) *	1997-06-30	1999-09-21	Endo Pharmaceuticals Inc.	Process for manufacturing paroxetine solid dispersions
CH689805A8 (fr) *	1998-07-02	2000-02-29	Smithkline Beecham Plc	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

1997
- 1997-06-10 SK SK1619-99A patent/SK283394B6/sk unknown
- 1997-06-10 DE DE69704679T patent/DE69704679T2/de not_active Expired - Lifetime
- 1997-06-10 TR TR1999/03025T patent/TR199903025T2/xx unknown
- 1997-06-10 EE EEP199900570A patent/EE03970B1/xx not_active IP Right Cessation
- 1997-06-10 BR BR9714787-7A patent/BR9714787A/pt unknown
- 1997-06-10 EE EEP200200633A patent/EE200200633A/xx unknown
- 1997-06-10 US US08/872,023 patent/US5874447A/en not_active Expired - Lifetime
- 1997-06-10 EP EP97926276A patent/EP0994872B9/en not_active Expired - Lifetime
- 1997-06-10 CA CA002293247A patent/CA2293247C/en not_active Expired - Lifetime
- 1997-06-10 TR TR2002/01156T patent/TR200201156T2/xx unknown
- 1997-06-10 PL PL97336895A patent/PL188450B1/pl not_active IP Right Cessation
- 1997-06-10 JP JP50212699A patent/JP2002503248A/ja not_active Ceased
- 1997-06-10 SI SI9730138T patent/SI0994872T1/xx unknown
- 1997-06-10 WO PCT/NL1997/000328 patent/WO1998056787A1/en not_active Ceased
- 1997-06-10 CZ CZ19994295A patent/CZ295301B6/cs not_active IP Right Cessation
- 1997-06-10 AU AU31080/97A patent/AU3108097A/en not_active Abandoned
- 1997-06-10 HU HU0003141A patent/HUP0003141A3/hu unknown
- 1997-06-10 DE DE29724281U patent/DE29724281U1/de not_active Expired - Lifetime
- 1997-06-10 ES ES97926276T patent/ES2155995T3/es not_active Expired - Lifetime
- 1997-06-10 DK DK97926276T patent/DK0994872T3/da active
- 1997-06-10 AT AT97926276T patent/ATE200781T1/de not_active IP Right Cessation
- 1997-06-10 EP EP00203910A patent/EP1078925A1/en not_active Withdrawn
- 1997-06-10 KR KR1019997011625A patent/KR100543614B1/ko not_active Expired - Fee Related
- 1997-06-10 IL IL13336697A patent/IL133366A/xx not_active IP Right Cessation
- 1997-06-10 PT PT97926276T patent/PT994872E/pt unknown
1998
- 1998-11-30 US US09/200,743 patent/US7598271B1/en not_active Expired - Lifetime
1999
- 1999-11-08 NO NO19995455A patent/NO317371B1/no unknown
- 1999-11-16 IS IS5249A patent/IS1927B/is unknown
- 1999-12-10 BG BG103980A patent/BG64315B1/bg unknown
2001
- 2001-04-26 GR GR20010400220T patent/GR3035784T3/el not_active IP Right Cessation
- 2001-05-16 US US09/855,710 patent/US6900327B2/en not_active Expired - Lifetime
2003
- 2003-08-25 NO NO20033766A patent/NO20033766D0/no not_active Application Discontinuation
- 2003-08-25 NO NO20033765A patent/NO20033765D0/no not_active Application Discontinuation
2004
- 2004-01-08 IS IS7098A patent/IS7098A/is unknown
2009
- 2009-01-23 US US12/358,997 patent/US20090326233A1/en not_active Abandoned

Also Published As

Publication number	Publication date
NO20033765D0 (no)	2003-08-25
WO1998056787A1 (en)	1998-12-17
TR199903025T2 (xx)	2000-07-21
TR200201156T2 (tr)	2002-07-22
PL188450B1 (pl)	2005-02-28
IS5249A (is)	1999-11-16
EE03970B1 (et)	2003-02-17
DK0994872T3 (da)	2001-05-28
US20010031767A1 (en)	2001-10-18
SK161999A3 (en)	2000-08-14
HUP0003141A3 (en)	2001-04-28
IS1927B (is)	2004-04-15
KR100543614B1 (ko)	2006-01-20
AU3108097A (en)	1998-12-30
CZ295301B6 (cs)	2005-07-13
BR9714787A (pt)	2000-07-18
KR20010013615A (ko)	2001-02-26
DE69704679T2 (de)	2001-09-13
US6900327B2 (en)	2005-05-31
HUP0003141A2 (en)	2001-03-28
ES2155995T3 (es)	2001-06-01
EE200200633A (et)	2003-02-17
PL336895A1 (en)	2000-07-17
US5874447A (en)	1999-02-23
SI0994872T1 (no)	2001-08-31
NO20033765L (no)	2000-02-09
BG103980A (en)	2000-07-31
NO20033766D0 (no)	2003-08-25
EP0994872B9 (en)	2001-12-05
US20090326233A1 (en)	2009-12-31
EP1078925A1 (en)	2001-02-28
BG64315B1 (bg)	2004-09-30
IS7098A (is)	2004-01-08
IL133366A0 (en)	2001-04-30
CA2293247A1 (en)	1998-12-17
ATE200781T1 (de)	2001-05-15
HK1027352A1 (en)	2001-01-12
US7598271B1 (en)	2009-10-06
EP0994872A1 (en)	2000-04-26
JP2002503248A (ja)	2002-01-29
CA2293247C (en)	2005-04-12
NO995455L (no)	2000-02-09
GR3035784T3 (en)	2001-07-31
EP0994872B1 (en)	2001-04-25
SK283394B6 (sk)	2003-07-01
IL133366A (en)	2005-11-20
DE69704679D1 (de)	2001-05-31
NO20033766L (no)	2000-02-09
DE29724281U1 (de)	2000-08-10
CZ429599A3 (cs)	2000-04-12
NO317371B1 (no)	2004-10-18
PT994872E (pt)	2001-09-28
EE9900570A (et)	2000-08-15

Publication	Publication Date	Title
NO20033765D0 (no)	2003-08-25	4-Fenylpiperidinforbindelser
CY1113054T1 (el)	2016-04-13	Παραγωγα διαμινης
DK0931788T3 (da)	2002-11-25	Metalloproteasehæmmere
MY119150A (en)	2005-04-30	Azetidine derivatives, their preparation and medicaments containing them
DK0600629T3 (da)	1996-06-10	N-acetonylbenzamider og deres anvendelse som fungicider
GB0318343D0 (en)	2003-09-10	No title
GR3003920T3 (no)	1993-03-16
DK0769296T3 (da)	2001-10-22	Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer
DE69702441D1 (de)	2000-08-10	Pyridinderivate als fungizide
NZ336091A (en)	2000-12-22	Aqueous disinfecting cleaning composition
AP2001002045A0 (en)	2001-03-31	FKBP inhibitors.
PL349933A1 (en)	2002-05-06	Novel compounds beta-hydroxyalylamides, method of obtaining them and their application
TW346483B (en)	1998-12-01	Benzene derivatives
RO91594A (ro)	1987-07-30	Compozitie erbicida solida
EP1020426A4 (en)	2003-02-05	AMINE DERIVATIVES AND THEIR PRODUCTION PROCESS
DK1140932T3 (da)	2004-07-05	Derivater af benzo-1,8-naphtyridin
GR3007320T3 (no)	1993-07-30
IT1306399B1 (it)	2001-06-06	Foratrice per cave di componenti curvi o inclinati di persiane.